CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats

Group 1 - Initial results from CervoMed's Phase 2b study in Dementia With Lewy Bodies did not show a statistically significant change on the study's primary endpoint [1] - The company attributed the lack of significant results to an old batch of neflamapimod [1]